In this articleHOODPat Freiermuth #88 of the Pittsburgh Steelers runs the ball during the fourth quarter of the NFL 2025 game against the Miami Dolphins at Acrisure Stadium on Dec. 15, 2025 in Pittsburgh, Pennsylvania.Lauren Leigh Bacho | Getty ImagesRobinhood is stepping up the capabilities of its fastest growing product — prediction markets — by giving users the ability to place what are essential parlay bets on multiple NFL games, putting it into direct competition with traditional sports books.Starting ...

Core Insights - Uxin Limited has officially opened its fifth used car superstore in Jinan, Shandong Province, enhancing its market presence in Northern China [1][2] - The Jinan superstore spans approximately 40,000 square meters and can display over 1,000 vehicles, supporting the shift towards standardized used car retailing [2] - Jinan, with over 4 million registered vehicles, is a significant automotive hub and a key driver of regional consumption growth, benefiting Uxin's operations [3] Company Expansion - The opening of the Jinan superstore completes Uxin's plan for three new superstores in 2025, with expectations to open four to six additional superstores in 2026 [4] - Uxin has strategic partnerships for new superstores in Guangzhou, Tianjin, and Yinchuan, with ongoing planning for other locations [4] Industry Positioning - Uxin is recognized as China's leading used car retailer, focusing on industry transformation through advanced production and digital empowerment [5] - The company offers a one-stop transaction experience with high-quality vehicles and superior after-sales services, leveraging an omni-channel strategy [5] - Uxin's extensive industry data and technology innovation have established strong management and operational capabilities in the used car sector [5]

Core Insights - The presentation highlights the company's unique brand, expanding farmer network, improved capacity, trusted retailer relationships, and attractive financial model [1]. Group 1 - The event is led by the President and CEO, Russell Diez-Canseco, along with other senior leadership team members [2]. - A Q&A session is planned after the presentation, followed by a lunch break and a tour of ECS and the new Cold Zone facility [2].

SHANGHAI, Dec 17 (Reuters) - MetaX Integrated Circuits jumped 700% in its Shanghai market debut as the Chinese AI chipmaker tapped into strong momentum triggered by Beijing's push to reduce reliance on chips from U.S. firms Nvidia (NVDA) and Advanced Micro Devices (AMD). Founded by former AMD executives, MetaX raised roughly $600 million in an initial public ​offering last week, days after larger rival Moore Threads debuted with a 400% pop. MetaX opened at 700 yuan a share in Shanghai versus an IPO pric ...

Good Morning, Asia. Here's what's making news in the markets: Welcome to Asia Morning Briefing, a daily summary of top stories during U.S. hours and an overview of market moves and analysis. For a detailed overview of U.S. markets, see CoinDesk's Crypto Daybook Americas.Crypto’s next $200 billion valuation debate may already be taking shape, and it looks a lot like Solana during the last cycle, according to a new report from Cantor Fitzgerald, which initiates coverage of Hyperion DeFi (HYPD) and Hyperliqui ...

Core Insights - Kioxia America, Inc. has integrated its AiSAQ technology into Milvus, enhancing the capabilities of one of the most widely adopted open-source vector databases for AI applications [1][2][3] Group 1: Technology Integration - The integration of Kioxia's AiSAQ technology into Milvus (starting with version 2.6.4) provides developers and enterprises with a cost-effective solution for scaling AI applications without high memory costs [1][2] - AiSAQ technology significantly reduces DRAM requirements while enabling high-quality vector search, making large-scale Retrieval Augmented Generation (RAG) deployments more accessible and affordable [2][3] Group 2: Market Demand and Challenges - As organizations adopt larger AI models and develop complex RAG pipelines, the demand for vector databases is increasing, with DRAM cost becoming a major barrier to growth [2][3] - Milvus now supports SSD-optimized vector indexing due to the integration of AiSAQ, which dramatically reduces memory usage while maintaining high-quality search performance [3][4] Group 3: Future Developments - Kioxia's AiSAQ technology is designed to enhance vector scalability by storing all RAG database elements on SSDs, with tuning options available to prioritize performance or scalability [4][5] - The ongoing development of AiSAQ aims to support trillion-vector scale, further advancing the capabilities of AI applications [4][5]

Core Viewpoint - The article discusses a securities class action lawsuit against CarMax, Inc. alleging that the company misled investors about its business stability and growth prospects, resulting in significant stock declines [2][4]. Summary by Sections Lawsuit Details - The lawsuit claims that CarMax and its executives concealed critical information regarding the company's operational challenges, leading to two major stock crashes [2][5]. - The class period for the lawsuit is defined as June 20, 2025, to November 5, 2025 [3]. Allegations - The complaint identifies two main issues that allegedly inflated the stock price: - **Unsustainable Demand**: CarMax reported strong growth for Q1 2026 but failed to disclose that this was due to a temporary surge in customer demand driven by anticipated tariffs [4]. - **CarMax Auto Finance Risk**: Management assured investors about the stability of their loan reserves, which later revealed a significant increase in loan loss provisions amounting to $142 million, a 40% sequential increase [4]. Impact on Business - The lawsuit highlights a distortion in core retail demand that could not be maintained in subsequent quarters, leading to a drastic cut in forward guidance and signaling systemic weaknesses in business operations [4]. - The stock experienced a 20% decline following the announcement of disappointing Q2 results, which included a 24% drop in net EPS and the unexpected loan loss provision [4]. Investor Actions - Investors who purchased CarMax securities during the class period and suffered losses are encouraged to contact Hagens Berman to discuss their rights and potential involvement in the lawsuit [5][6].

Core Insights - Affirm's stock surged by 10.2% on a day marked by a broader upswing in the buy-now/pay-later (BNPL) and fintech sectors, influenced by a weaker-than-expected jobs report that may lead to lower interest rates [1][4][5] Company Performance - Affirm's CFO Rob O'Hare highlighted a five-year partnership extension with Amazon, which is expected to drive new customer acquisition for both companies [2][6] - The company reported a 34% increase in revenue and a GAAP operating margin of 7% in its most recent quarter, indicating strong growth and profitability [9] - Credit trends remained stable, with delinquency rates consistent with previous years, suggesting that the company's credit model is holding up [10] Market Context - The positive market reaction to Affirm's performance was also reflected in other BNPL and fintech stocks, which experienced gains due to favorable market conditions and investor sentiment [5] - The partnership with Amazon was described as a "win-win," with terms remaining mostly unchanged, reinforcing Affirm's leadership in the industry [6][9] - Evercore ISI maintained an outperform rating for Affirm, with a price target of $95, reflecting confidence in the company's future performance [7]

Ross Gerber seems to always speak his mind when it comes to Tesla (NASDAQ:TSLA) CEO Elon Musk. “I’m not a fan of Elon,” Gerber said during a recent episode of the “Chasing Finance” podcast. “But I’m not going to deny the fact he builds great products.” ‘He’s built some big companies and he’s succeeded,” Gerber added. “People are willing to pay a premium for this guy who works 24/7, who, you know, has built some great products.” Gerber Still Believes in Tesla’s Potential, But Not Blindly While the promin ...

Nektar Therapeutics (NASDAQ: NKTR) is a biopharmaceutical company focusing on autoimmune diseases, oncology, and pain management.H.C. Wainwright set a price target of $135 for NKTR, indicating a potential price increase of approximately 164%.Recent Phase 2b REZOLVE-AA trial results for rezpegaldesleukin showed significant potential in treating severe-to-very-severe alopecia areata.Nektar Therapeutics (NASDAQ: NKTR) is a biopharmaceutical company focused on developing innovative medicines in areas of high un ...